ALBERT DAVID
|
The Current P/S Ratio of ALBERT DAVID is 1.34.
| Share Price | ₹745.0 | Dec 18,2025 |
| Market Cap | ₹424.7 Cr | |
| Sales-TTM | ₹315.8 Cr | TTM-Standalone Results |
| Price/Sales | 1.34x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ALBERT DAVID
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹424.7 Cr] as on Dec 18,2025
(/) Sales [ ₹315.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.34x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay '1.34 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ALBERT DAVID !
The chart below summarizes the trend in P/S Ratio of ALBERT DAVID over the last five years.
Historical PS (Price/Sales) ratio chart of ALBERT DAVID
PS Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.15x.
- ALBERT DAVID 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2024 at 1.69x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 0.86x.
How does ALBERT DAVID 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ALBERT DAVID | 315.8 | 1.34 | 424.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.62 | 418,768.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.89 | 169,385.0 |
| CIPLA LTD | 28,349.6 | 4.27 | 121,093.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.39 | 127,242.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.11 | 106,799.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.52 | 88,468.2 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.75 | 91,954.7 |
| LUPIN LTD | 24,750.7 | 3.91 | 96,761.4 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.16 | 70,271.2 |
| ABBOTT INDIA LTD | 6,714.4 | 8.82 | 59,231.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ALBERT DAVID 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.34x |
| Max industry PS | 16.89x |
| Median industry PS | 4.27x |
| Average industry PS | 6.25x |
You may also like the below Video Courses